PBMs. What Are They Hiding? w/ Stacie Dusetzina

This episode is brought to you by Semafor Healthcare.

Delivered weekly from David Lim, Semafor Healthcare connects the dots between decisions in government, business, and technology to reveal how they impact the future of healthcare. Each edition will provide the analysis you need to understand and stay ahead of a rapidly changing landscape. Subscribe for free.

Health Affairs' Jeff Byers welcomes Stacie Dusetzina of Vanderbilt University back to the program to discuss an interim staff report released by the Federal Trade Commission (FTC) about the impact that pharmacy benefit managers (PBMs) have on the accessibility and affordability of prescription drugs.

Check out the August 2024 issue of Health Affairs.

RSVP for our upcoming Age-Friendly Health Briefing entitled "What Do Recent Nursing Home Developments Mean for Residents, Families, and the Future of Long-Term Care?" in partnership with The John A. Hartford Foundation.

Become an Insider to not miss out on Stacie Dusetzina's exclusive newsletter, Policy Prescription, which focuses on drug pricing.

Related Articles:

• PRESS RELEASE: FTC Releases Interim Staff Report on Prescription Drug Middlemen
• Merging Medical And Drug Benefits: Seeing The Whole Picture (Health Affairs Forefront)
• Three Key Ways To Strengthen Proposed Pharmacy Benefit Manager Regulations (Health Affairs Forefront)

Subscribe to Semafor Healthcare for free.